Beam Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	288.29	294.94	281.97	435.9	232.77	559.99
Short-Term Investments	923.36	950.27	568.77	753.98	845.37	405.65
Cash & Short-Term Investments	1,212	1,245	850.74	1,190	1,078	965.65
Cash Growth	-0.68%	46.37%	-28.50%	10.37%	11.65%	222.24%
Other Receivables	-	-	-	-	-	300
Total Trade Receivables	-	-	-	-	-	300
Other Current Assets	55.3	23.48	27.41	21.17	14.76	7.36
Total Current Assets	1,267	1,269	878.15	1,211	1,093	1,273
Net Property, Plant & Equipment	199.4	205.18	216.28	237.81	234.13	186.98
Other Long-Term Assets	14.45	7.31	9.4	10.87	14.69	14.47
Total Assets	1,481	1,481	1,104	1,460	1,342	1,474
Accounts Payable	12.29	10.23	3.87	1.62	9.03	7.47
Accrued Expenses	39.29	55.27	47.47	111.66	49.91	67.66
Current Portion of Long-Term Debt	-	-	-	-	-	2.29
Current Portion of Leases	14.78	14.36	13.47	12.78	10.38	7.54
Unearned Revenue	0.3	6.66	108.86	68.71	135.97	86.27
Other Current Liabilities	7.9	10.41	8.4	10.8	18.3	42.2
Total Current Liabilities	74.57	96.94	182.07	205.57	223.6	213.44
Long-Term Debt	100.19	-	-	-	-	3.01
Long-Term Leases	135.85	139.76	147.96	159.91	168.63	134.81
Other Long-Term Liabilities	5.75	6.13	40.26	112.91	216.02	296.46
Total Long-Term Liabilities	241.8	145.88	188.21	272.82	384.65	434.28
Total Liabilities	316.36	242.82	370.28	478.39	608.24	647.72
Common Stock	1.03	1.02	0.84	0.82	0.71	0.68
Additional Paid-in Capital	2,900	2,877	2,299	2,170	1,793	1,594
Accumulated Other Comprehensive Income	-1.07	1.11	0.68	0.6	-2.43	-0.05
Retained Earnings	-1,736	-1,641	-1,567	-1,190	-1,057	-768.27
Shareholders' Equity	1,164	1,238	733.55	981.33	733.47	826.74
Total Liabilities & Equity	1,481	1,481	1,104	1,460	1,342	1,474
Total Debt	250.82	154.12	161.43	172.69	179.01	147.64
Net Cash (Debt)	960.83	1,091	689.32	1,017	899.13	818
Net Cash Growth	-11.94%	58.29%	-32.23%	13.13%	9.92%	325.98%
Net Cash Per Share	9.31	11.03	8.37	13.18	12.84	12.74
Book Value	1,164	1,238	733.55	981.33	733.47	826.74
Book Value Per Share	11.28	12.52	8.91	12.72	10.48	12.87
Tangible Book Value	1,164	1,238	733.55	981.33	733.47	826.74
Tangible Book Value Per Share	11.28	12.52	8.91	12.72	10.48	12.87

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q